Peer Review History
| Original SubmissionNovember 1, 2024 |
|---|
|
Dear Dr. 司徒, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ihssan S. Masad, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 6. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: General: The introduction needs to be reworked. There are some irrelevant details (see comments) and some missing information. For instance, why no background on CNN or more detailed discussion of prior image classification work? Also, the purpose/approach of the study should be clarified. Was there any attempt to measure distance to participants or otherwise quantify their position in space? This seems important and is not addressed. What are other alternatives to this approach? I think this paper is missing any comparison to current work. Pose estimation is quite good these days and there are likely off-the-shelf products that could aid in real-time positioning of a patient. One could even imagine a simple edge detection algorithm could be used here. Your approach is reasonable in a vacuum, but the paper is missing justification and context, especially considering that the only measure used is whether or not the patient is “too high” or “too low”. The results section is limited. It seems to be missing a reference to the Grad-CAM results. There is not anything on the training or validation of the model. I would be interested in seeing some of the testing that went in to selecting your hyper-parameters too. I would include baseline example images of each category. Figure one has images that are unlabeled, and it is not clear what is what. The figures in general seem a bit blurry and do not have good/description legends. I have somewhat of a problem with the simple categories. They are very limited. What is too high? What is too low? How is that actually determined (outside of expert opinion)? What about distance from patient? Posture? Etc. Is that the only issue that is present? What if someone is just a little too high or a little too low? These categories are presented without good context. I also wonder if your categories correlate at all with end image quality (the actual x-rays). This is very important I think for the practical application and it is not addressed here. Specific: Lines 36 – 40: Why do you mention fluoroscopy here? I don’t see how this section fits into the introduction. Fluoroscopy is a separate technique that would not necessarily be used in place of chest x-ray (or vice versa). I don’t see the reason for the comparison. This section does not add anything of value. I would suggest removing it or rewriting it to better integrate with the paper. I would rather see background about where and how x-ray might be used. Lines 41-48: This feels like a better start to the introduction and is more relevant to the research question. I would consider integrating this paragraph and the first to improve flow. Lines 45-48: I would like to see some citations here. Has there been prior work done? Why is this an issue? Please expand more here. Lines 55-59: I think that you need to clarify that this modeling is attempting to use external camera data to aid in positioning. It is not obvious. Lines 83 – 84: Was the classification solely based on visual distance/positioning? I would think that the resulting x-ray should be the standard here i.e., that the images are graded based on the clarity/positioning/quality of the end result image. Why was this not done? Line 87: Please specify what the “No-one” and “Others” classifications mean. Lines 94-95: Why such a comparatively small test set? Line 99: How is this different from conventional models? Are you referring to a particular architecture? A CNN with 2 convolutional layers and 3 fully connected layers does not strike me as unusual. Line 115: I am surprised by this low batch size produces the best results. It isn’t unreasonable, it is just lower than usual (for a “low” batch size). Lines 132-134: What was the result here? Did you make any changes to the model? The referenced figure is interesting, but it isn’t obvious to me what you did with that info. Lines 154-156: It seems that this is repeated from table 1. I do not think the information needs to be in both places. The table doesn’t really add much. Additionally, it is confusing to read, at a minimum I would add acronyms to the legend. Line 158: Why is this section not in the intro? I don’t think it belongs in the discussion. Line 169: This entire subsection is a mishmash of information that belongs elsewhere. The Grad-CAM results should be in the results section. The methods should mention that you tested multiple configurations of convolutional layers. It is not clear what is considered a well-positioned x-ray. Line 201: “the TNR of 0.95.6” should this be “0.956”? Lines 208-209: This seems to be a major limitation in the training set. I would be interested to know what the performance was for each category. For example, what was the accuracy of each category? Were there discrepancies? Reviewer #2: Your manuscript is technically strong and provides valuable data to support its conclusions. However, there are a few areas where refinements could further enhance the clarity, rigor, and practical relevance of the work. *Model validation The reported accuracy metrics are impressive, but the validation and test sets are relatively small compared to the training data. It would be helpful to discuss whether the results are generalizable to broader populations or different imaging setups. Additionally, consider addressing how the model might perform in varied real-world scenarios, such as with different equipment or patient positions, to better illustrate its robustness. *Statistical analysis Your study employs solid and appropriate statistical methods, but there are a few areas where additional details could enhance the clarity and reliability of the results. Confidence Intervals (CIs): Including confidence intervals for key performance metrics like accuracy, sensitivity, specificity, and precision would provide a clearer picture of how consistent and reliable these metrics are. Confidence intervals offer insight into the potential variability of your results and allow readers to assess how robust your findings are in different scenarios. Class imbalance: The imbalance in image categories, such as "Too Low," could potentially affect the model’s performance metrics. To address this, consider reporting class-specific metrics, such as precision, recall, and F1-scores for each category. This will help highlight any discrepancies in performance across the different classes and ensure transparency about how well the model handles underrepresented categories. Statistical comparisons: If you are comparing the performance of your model to other baseline methods or alternative approaches, it would be beneficial to include statistical significance testing. For instance, using McNemar’s test for paired categorical data can help demonstrate whether differences in performance are statistically meaningful. This will make your claims about the model’s superiority more compelling. Model calibration: Providing an evaluation of your model’s calibration, such as a calibration curve or metrics like the Brier score, would be particularly useful for readers. This would show how well the predicted probabilities align with actual outcomes, which is critical in clinical applications where confidence in predictions can directly impact patient care. Variability assessment: Consider employing techniques like bootstrapping or cross-validation to assess the variability of your metrics across different data subsets. This would provide a more comprehensive view of your model’s generalizability and reliability, helping readers understand how it might perform in broader applications. *Presentation and Writing Overall, the manuscript is well-written, but some sections, particularly the methodology, feel overly dense. Simplifying the language and structure in these areas would make the content more accessible to a wider audience. Additionally, figures and tables are useful, but captions for Figure 3 (training process) and Figure 4 (Grad-CAM) could be expanded to better explain their relevance and key takeaways. *Discussion of limitations The discussion does not fully explore some of the limitations of the study. For example, the imbalance in image categories, such as "Too Low," may affect the model’s performance. It would be beneficial to address this issue and propose strategies for handling similar imbalances in future research. *Future directions and practical implications Your manuscript hints at the practical implications of the AI model, such as reducing the workload of radiologic technologists. Expanding on this by discussing challenges related to clinical integration—like addressing ethical considerations and providing user training—would add depth to the discussion. This would help readers better understand how your model could be implemented in real-world clinical settings. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. 司徒, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ihssan S. Masad, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Partly Reviewer #4: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: (No Response) Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: (No Response) Reviewer #4: Yes ********** Reviewer #1: (No Response) Reviewer #3: Thank you for the opportunity to review your manuscript titled "A Deep Learning AI Model for Determining the Relationship Between X-Ray Detectors and Patient Positioning in Chest Radiography." Your work addresses a highly relevant and timely topic, especially as AI continues to influence the optimisation of imaging protocols and the improvement of diagnostic quality in medical imaging. The manuscript presents a promising application of deep learning to assess patient positioning in relation to X-ray detector alignment a factor critical for image quality and diagnostic accuracy. The use of AI to provide potential decision support or automated feedback to radiographers has clear clinical implications, particularly in standardising chest radiography practices and minimising repeat exposures. Strengths of the manuscript include: -A well-motivated research problem with clear clinical relevance. -Appropriate use of deep learning methodology. -Potential for integration into clinical workflows for quality assurance or education. However, there are a few areas that could benefit from further clarification or development: 1.Model Explainability: Consider expanding on how the model's outputs (e.g., heatmaps or classification scores) are interpreted in the context of positioning accuracy. 2.Data Description: Please provide more detail regarding the dataset used, such as the size, diversity of cases (e.g., supine vs. erect exams, if this variation was used), and how positioning quality was labelled. 3.Clinical Validation: It would strengthen the paper to include or suggest a pathway for clinical validation, especially if the model will be used in actual clinical radiography settings. 4.Discussion of Limitations: While the model's performance is promising, a more detailed discussion of its current limitations and generalisability to other institutions or equipment types would enhance transparency. Overall, the manuscript makes a valuable contribution to the field of AI in radiography and could be further strengthened by addressing the above points. I encourage the authors to refine the manuscript based on the below focused feedback and look forward to seeing this work contribute to improved imaging practices in clinical environments. Introduction: line 56 -57 Suggestion: In or before this paragraph, include a brief Hx of the ResNet architecture and how it has made a contribution to medical imaging advancements Study design: line 96 -97 Should this not be in the past tense if it was a completed action? Materials and methods: line 155 Include what led to the selection of the ResNet18 specifically vs. ResNet34 or other architectures - I am not sure if I have missed in in the manuscript. In text and Table data Should this not align with what you have in text because elsewhere there’s spacing or formatting variation (e.g., “Model A”, “ModelA”). In some places you have model and in others modle Discussion: line 251 Include a limitations subsection Under future works and outlooks- line 338 Was this not a limitation? Conclusion: Reword to include broader implications or future integration with the hospital workflows. Reviewer #4: The objective of this manuscript is to develop an AI system to precisely determine the spatial relationship between the X-ray detector and the patient during chest radiography. While this is a relevant and clinically significant goal, I have several concerns and suggestions regarding the proposed methodology and the presentation of the work. 1. The manuscript claims to develop an AI system, but it primarily employs relatively simple or already established models. The methodological novelty or technical innovation needs to be clearly demonstrated. A detailed explanation or justification for the choice of models, including an analysis of the model architecture, theoretical basis, and rationale for selecting specific AI algorithms, is essential. In high-stakes medical applications, models require extensive validation, tuning, and interpretability to be considered reliable. 2. The Methods, Results, and Discussion sections are described in broad terms and lack the scientific precision expected in a research manuscript. It would be helpful if the methods were detailed more thoroughly to improve the reproducibility and credibility of the work. Similarly, the Results and Discussion should be supported by clear descriptions, thorough analysis, and well-structured interpretation. 3. The data source section lacks clarity. For example, in line 113, the term “images deemed irrelevant” is vague—please specify the exclusion criteria. The manuscript should also clarify the standards for data inclusion, exclusion, and cleaning. Additionally, the five classification categories are not clearly defined. Similar ambiguities appear throughout the manuscript and should be addressed. 4. In line 146, the manuscript mentions reviewing numerous journals but cites only a few references from the same source. I recommend expanding the literature review to include a broader and more diverse range of high-impact references. Moreover, the novelty of the proposed model remains unclear—it would be helpful if the manuscript clarified how it differs from existing approaches, including reference [17]. 5. Please include a more thorough explanation of how the dataset was divided into training, validation, and test sets. If cross-validation or folds were used, a clear description of the process would improve understanding. 6. If there are existing published methods that address similar problems, it would be helpful to include comparisons. 7. Given the clinical implications, I suggest a more comprehensive evaluation strategy. Referring to earlier peer-reviewed studies that have applied validated techniques (before 2022) could strengthen the validation. 8. Is there any limitations of the proposed approach? 9. The manuscript would benefit from careful language editing to enhance clarity and professionalism. For instance, the term “take” in the short title is unclear. Additionally, the phrase “daily chest X-ray” in the abstract, does it refer to routine imaging? Clarification would be helpful. 10. Figures and tables should be clearly labeled and thoroughly explained. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
A Deep Learning AI Model for Determining the Relationship Between X-Ray Detectors and Patient Positioning in Chest Radiography PONE-D-24-42489R2 Dear Dr. 司徒, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ihssan S. Masad, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewer #3: Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes ********** Reviewer #3: I would like to thank the authors for carefully considering and addressing the feedback provided on the previous version of the manuscript. The revisions have substantially improved the clarity, methodological rigor, and overall quality of the paper. I appreciate the effort made to incorporate the suggested changes and provide detailed responses to the comments. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-42489R2 PLOS ONE Dear Dr. Situ, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ihssan S. Masad Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .